Sunday, Oct 25, 2026

"covaxin-phase-3"

Bharat Biotech rejects criticism on ‘Covaxin’ approval

The approval to Covaxin has been questioned by industry experts and some opposition Congress leaders who have expressed concern over the absence of phase 3 trial data

Latest News

Teddy tigers and preserved embryos: Museum in Corbett tries to keep them ‘alive’

1 minute ago
Aaryavir Sehwag has quality to play for India, but needs to take things step by step, says Delhi U-19 coach Nayyar

11 minutes ago
Govt extends deadlines for FY26 annual filing, waives additional fees for companies

19 minutes ago
Chennai reservoirs record significant boost in storage after nine days of rain

44 minutes ago
Adani Group refutes social media claims over alleged tree felling near Bhimashankar Temple

1 hour ago
Iran’s supreme leader meets judiciary chief, urges compensation for US-Israeli ‘crimes’

1 hour ago
Zelensky says Ukraine ready to freeze front lines but rejects territorial concessions

1 hour ago
Tension prevailed in Hyderabad’s Madannapet

1 hour ago